Marketplace®
Every story is an economic story
Mar 20, 2018

03/20/2018: The potential costs of a drug coupon

(U.S. Edition) The U.K.-based data firm Cambridge Analytica continues to be embroiled in scandal. We’ll look at how investors are reacting to reports that it used Facebook data to manipulate voters on behalf of the Trump campaign, and then talk about the release of a video showing Cambridge’s CEO claiming his company was able to entrap foreign politicians. Plus: A look at why some states are pushing back against pharmaceutical coupons for branded drugs. 

A pharmacy manager assists a shopper in the pharmacy area of a Walmart store in Mount Prospect, Illinois.
A pharmacy manager assists a shopper in the pharmacy area of a Walmart store in Mount Prospect, Illinois.
Tim Boyle/Getty Images

Subscribe:

(U.S. Edition) The U.K.-based data firm Cambridge Analytica continues to be embroiled in scandal. We’ll look at how investors are reacting to reports that it used Facebook data to manipulate voters on behalf of the Trump campaign, and then talk about the release of a video showing Cambridge’s CEO claiming his company was able to entrap foreign politicians. Plus: A look at why some states are pushing back against pharmaceutical coupons for branded drugs.